Laser Photonics Corporation announced on October 31, 2024, that it signed a definitive asset purchase agreement to acquire Control Micro Systems, Inc. (CMS). This acquisition is expected to strategically broaden Laser Photonics' market reach, engineering talent, and technology portfolio.
The acquisition is anticipated to provide entry into the pharmaceutical and medical manufacturing vertical, a recession-resistant sector with high barriers to entry. CMS specializes in laser solutions for controlled-release tablets and traceability of medications, working with world-class pharmaceutical companies.
Laser Photonics plans to leverage its existing sales and marketing infrastructure to unlock additional value from CMS, which it believes was undervalued due to a lack of investment. The company also intends to hire all existing CMS employees, including engineers and customer support personnel, to ensure a seamless transition and enhance its capabilities.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.